Background: Lymphoedema is a common complication of breast cancer treatment
, affecting approximately a quarter of patients. Those affected can have an
uncomfortable, unsightly and sometimes functionally impaired limb prone to
episodes of superficial infection. The aetiology, pathophysiology and mana
gement of these patients is poorly understood.
Methods: This is a systematic review of all published literature on lymphoe
dema following treatment for breast cancer, using the Medline and Cinahl da
tabases with cross-referencing of major articles on the subject up to the e
nd of 1999.
Results and conclusion: The aetiology and pathophysiology of lymphoedema in
patients with breast cancer appear to be multifactorial and are still not
fully understood. Although conservative treatment techniques can be very su
ccessful in controlling symptoms, they do not afford a cure. The place of s
urgical and pharmacological therapy remains unclear. Improved understanding
of the pathophysiology may assist in reducing the incidence of this condit
ion, or help to identify those at greatest risk, in whom early initiation o
f conservative treatment measures may prove effective.